Literature DB >> 2820982

The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein.

H P Haagsman1, S Hawgood, T Sargeant, D Buckley, R T White, K Drickamer, B J Benson.   

Abstract

SP 28-36, a major protein of pulmonary surfactant, has striking amino acid sequence homology with soluble mannose-binding proteins isolated from rat liver and contains residues common to the carbohydrate-binding domains of other mammalian lectins. We have used carbohydrate-affinity chromatography to investigate carbohydrate-binding properties of SP 28-36 isolated from canine and human (alveolar proteinosis patients) lung lavage. SP 28-36 binds to immobilized D-mannose, L-fucose, D-galactose, and D-glucose. The protein binds only weakly to N-acetyl-D-galactosamine and N acetyl-D-glucosamine. Binding is Ca2+-dependent. The threshold Ca2+ concentration is 0.6 mM and maximal binding occurs with 1 mM Ca2+. Bound protein is quantitatively recovered by elution with 2 mM EDTA. Ba2+, Sr2+, and Mn2+, but not Mg2+, can substitute for Ca2+. Unlike some other mammalian lectins, SP 28-36 binds to carbohydrate at pH 5.0. Recombinant human SP 28-36 isolated from the media of Chinese hamster ovary cells, transfected with a DNA construct encoding SP 28-36, has similar carbohydrate-binding activity to the native proteins. Mannose affinity chromatography of the culture medium of Chinese hamster ovary cells results in an efficient purification of the secreted recombinant human SP 28-36.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820982

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Differential effects of surfactant protein A on regional organization of phospholipid monolayers containing surfactant protein B or C.

Authors:  S G Taneva; K M Keough
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Lipid specificity of surfactant protein B studied by time-of-flight secondary ion mass spectrometry.

Authors:  D Breitenstein; J J Batenburg; B Hagenhoff; H-J Galla
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

3.  Surfactant protein composition of lamellar bodies isolated from rat lung.

Authors:  M A Oosterlaken-Dijksterhuis; M van Eijk; B L van Buel; L M van Golde; H P Haagsman
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

4.  Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.

Authors:  Guirong Wang; Svetla Taneva; Kevin M W Keough; Joanna Floros
Journal:  Biochim Biophys Acta       Date:  2007-07-06

5.  Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.

Authors:  Anatoly N Mikerov; Guirong Wang; Todd M Umstead; Mario Zacharatos; Neal J Thomas; David S Phelps; Joanna Floros
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

6.  Comparison of the Maclura pomifera lectin-binding glycoprotein in late fetal and adult rat lung.

Authors:  M J Kresch; J Lwebuga-Mukasa; C M Wilson; I Gross
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 7.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 8.  Pulmonary surfactant and its apoproteins.

Authors:  S Hawgood; J A Clements
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 9.  The role of surfactant-associated protein A in pulmonary host defense.

Authors:  V L Shepherd; J P Lopez
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

10.  Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants.

Authors:  Anatoly N Mikerov; Todd M Umstead; Xiaozhuang Gan; Weixiong Huang; Xiaoxuan Guo; Guirong Wang; David S Phelps; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-02       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.